You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)

Completed
Has Results
  • Colon Cancer
  • +3 more
  • Birmingham, Alabama
  • +94 more
Nov 10, 2022

Colorectal Cancer Trial in Japan (oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab, oxaliplatin (OXA),

Active, not recruiting
  • Colorectal Cancer
  • oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab
  • oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, bevacizumab
  • Ichinomiya, Aichi, Japan
  • +150 more
Nov 29, 2022

Metastatic Colorectal Cancer Trial in France (Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, Panitumumab, oxaliplatin,

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan
  • Avignon, France
  • +5 more
Aug 2, 2022

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI plus Bevacizumab, mFOLFOX6 Plus Bevacizumab)

Recruiting
  • Colorectal Cancer
  • mFOLFOXIRI plus Bevacizumab
  • mFOLFOX6 Plus Bevacizumab
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Jun 15, 2022

Metastatic Colorectal Cancer Trial in Berlin (Panitumumab 20 milligram/ML, Bevacizumab, Trifluridine/Tipiracil Hydrochloride)

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab 20 milligram/ML
  • +2 more
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin
Jul 20, 2022

Metastatic Colorectal Cancer Trial in Wuhan (Fruquintinib Combined With mFOLFOX6/FOLFIRI)

Recruiting
  • Metastatic Colorectal Cancer
  • Fruquintinib Combined With mFOLFOX6/FOLFIRI
  • Wuhan, Hubei, China
    Zhongnan Hopital of Wuhan University
Oct 25, 2022

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Colorectal Cancer Trial in Japan (oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab, oxaliplatin (OXA),

Completed
  • Colorectal Cancer
  • oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab
  • oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, bevacizumab
  • Ichinomiya, Aichi, Japan
  • +154 more
Feb 7, 2022

Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Madrid, Spain
    Spanish Cooperative Group for the Treatment of Digestive Tumors
Mar 8, 2022

Metastatic Colorectal Cancer (CRC) Trial (TRS003, China-approved Bevacizumab, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer (CRC)
  • TRS003
  • +2 more
  • (no location specified)
May 12, 2022

(NCT02394834) in Advanced/Recurrent Colorectal Cancer

Recruiting
  • Colorectal Cancer
  • mFOLFOX6 + panitumumab combination therapy
  • mFOLFOX6 + bevacizumab combination therapy
  • Tokyo, Japan
    Takeda selected site
Sep 28, 2021

Colorectal Tumors Trial in United States (tucatinib, trastuzumab, bevacizumab)

Recruiting
  • Colorectal Neoplasms
  • Anaheim, California
  • +13 more
Aug 15, 2022

Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • mFOLFOX6 + Cetuximab
  • mFOLFOX 6
  • Shanghai, China
    Zhongshan hosptial, Fudan University
Jul 14, 2023

Advanced/Metastatic Colorectal Cancer Trial in Guangzhou (Dalpiciclib, Oxaliplatin injection, Calcium folinate)

Not yet recruiting
  • Advanced/Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    Sixth Affiliated Hospital, Sun Yat-sen University
Jul 28, 2022

Metastatic Colorectal Cancer Trial in Sutton (PDR001, bevacizumab, mFOLFOX6)

Terminated
  • Metastatic Colorectal Cancer
  • Sutton, Surrey, United Kingdom
    Novartis Investigative Site
Oct 7, 2021

Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Oct 24, 2023

Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant

Not yet recruiting
  • Multiple Cancer
  • Colorectal Cancer
  • MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
  • All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
  • (no location specified)
Aug 20, 2023

Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022

Metastatic Colorectal Cancer Trial in Italy (Panitumumab, Irinotecan, Oxaliplatin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
  • +3 more
Oct 5, 2021

Metastatic Colorectal Cancer Trial in Madison (Liposomal irinotecan, TAS102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Liposomal irinotecan
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
May 2, 2023

Trifluridine/Tipiracil Plus Bevacizumab Versus

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 11, 2023

Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

Not yet recruiting
  • Unresectable Metastatic Colorectal Cancer
  • (no location specified)
Oct 25, 2023

EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

Recruiting
  • EGFR NP_005219.2:p.S492R
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Colorectal Cancer Trial (ME-344, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 20, 2023

Metastatic Colorectal Cancer (mCRC) Trial in Nanjing (HLX04 100 mg in 4 ml Injection, Avastin 100 mg in 4 ml Injection)

Active, not recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • HLX04 100 mg in 4 ml Injection
  • Avastin 100 mg in 4 ml Injection
  • Nanjing, Jiangsu, China
    Nanjing Bayi Hospital Ethics Committee
May 6, 2022